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The aim of this study was to compare the central inspiratory drive (P0.1) response to
hypoxia and hypercapnia between different age groups of elderly, nonsmoker, healthy
subjects and young healthy controls.
A random sample, proportionally stratified by age (65–69, 70–74, 75–79 and 80–84 yrs)
from a sample of nonsmoker elderly subjects representative of a general population and 47
healthy subjects aged 20–40 were selected. Arterial blood gas, lung volumes, diffusing
capacity, maximal respiratory pressure and oxygen uptake measurements were performed.
Breathing pattern and mouth occlusion pressure, as well as P0.1 responses to hyperoxic
progressive hypercapnia and isocapnic progressive hypoxia were evaluated.
The elderly subjects had lower P0.1 responses to hypoxia (0.01770.006 vs.
0.03170.008 kPa/%, Po0.001) and hypercapnia (0.04270.018 vs. 0.05170.030 kPa/
mmHg, P ¼ 0.047) than the young healthy controls.
Hypoxic sensitivity gradually decreased as age increased to 70–74 and remained unchanged
from 75 years of age onward. CO2 threshold was lower in the elderly groups than in young
healthy controls. Lung volumes, inspiratory muscle strength and baseline metabolic rate
were the principal determinants of hypoxic sensitivity.
In summary, during old age, a progressive decline in hypoxic sensitivity and a decrease in
the CO2 threshold are experienced. These alterations remain stable from the age of 75
onward.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Although it is well known that the ageing process induces a
series of modifications in lung structure and function,1,2Elsevier Ltd. All rights reserved.
300170; fax: +34 91 7277096.
(F. Garcı´a-Rı´o).its repercussions on the breathing regulation system
are not so well defined. Nevertheless, the deterioration of
blood gasses seems to be a factor implicated in the
increase in morbidity and mortality experienced by the
elderly.2 It is widely accepted that hypoxemia actively
participates in multiple causes of mortality, such as
stroke, myocardial infarction and chronic lung disease, and
that sensitivity to CO2 is critical in the development of
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drome.3–5
The repercussions of the ageing process on chemosensi-
tivity are imprecise. Some authors6–9 have observed that
ageing patients presented lower ventilatory responses to
hypoxia and hypercapnia than young healthy subjects.
Meanwhile, other studies did not detect that old age
modified either sensitivity to hypoxia10,11 or hypercap-
nia.12,13 This discordance among the studies mentioned
could be due to different methodological aspects. With the
exception of the studies by Peterson et al.8 and Pokorski and
Marczak11 the remainder only analysed the ventilatory
response to CO2 and hypoxia. Given that the ageing
process produces alterations in lung structure that
condition changes in respiratory mechanics and even in
the strength of the respiratory muscles,1,2 it is possible that
the ventilatory response does not adequately reflect the
actual neural impulse that reaches the respiratory
muscles.14
Another aspect to consider is the sample type used in
previous studies.6–13 In the article by Peterson et al.8 only 10
subjects aged 65–79 were studied. The remaining authors
also used very small samples and similar age intervals. This
latter aspect could be important if it is assumed that ageing
is a progressive physiological process, and as such the
changes it induces can differ among elderly subjects of
different ages. In this regard, Cerveri et al.15 demonstrated
that the progressive decrease in PaO2 lessens after the age
of 75, probably due to either an alteration in the
ventilation–perfusion relationship secondary to weight loss,
a process of natural selection, or the existence of
unidentified alterations in breathing control itself.15 Last
of all, and from a clinical perspective, it could be useful to
identify those factors related to the modifications that
ageing induces in chemosensitivity as well as to define
reference equations to determine predictable degrees of
deterioration.
To our knowledge, the behaviour of chemosensitivity has
still not been evaluated throughout the different stages of
ageing. The objective of the present study was to compare
central inspiratory drive response, evaluated using mouth
occlusion pressure (P0.1), to hypoxic and hypercapnic
stimulation in healthy elderly subjects of different age
intervals and healthy young controls.Methods
Study subjects
From a randomly selected sample of nonsmoker elderly
subjects representative of the general population of the
Madrid, Spain metropolitan area,16 a random sample was
drawn by electronic selection and proportionally stratified
by age (65–69, 70–74, 75–79 and 80–84 yrs). In order to
detect significant differences in the inspiratory drive
response to progressive isocapnic hypoxia of at least
0.003 kPa/% with an alpha risk of 0.05 and a beta risk of
0.2, a minimum of 15 subjects in each age group was
estimated to be necessary.17 Assuming a loss of 15%, we
selected 18 subjects for each group. Moreover, to detect
significant differences in the inspiratory drive response toprogressive hyperoxic hypercapnia of at least 0.001 kPa/
mmHg18 with an alpha risk of 0.05, a beta risk of 0.2 and a
loss of 15%, a minimum of 11 subjects in each age group was
estimated as necessary. For the control group, 47 healthy
subjects aged 20–40 were recruited from the same area. The
selection criteria and procedures have been previously
described at length.16
Subjects were asked not to eat for 4 h before the study,
and they were also asked to refrain from using coffee, tea
and alcohol for X12 h before each study. The study was
approved by the local Ethics Committee and all subjects
gave their written informed consent prior to enrolment.Measurements
Pulmonary function tests were performed as previously
described,19 with subjects seated and always in the same
order, allowing for enough rest between each manoeuvre.
All procedures were performed by the same technician, who
was blinded to the results.
Arterial blood gas values breathing room air were
measured. Spirometry was performed by means of a
pneumotachograph and static lung volumes were measured
with a constant-volume body plethysmograph (MasterLab
Body, Erich Jaeger GmbH, Wu¨rzburg, Germany) according to
European Respiratory Society standards.20 Diffusing capacity
for carbon monoxide was determined by the single-breath
method (MasterLab Body). Resting oxygen uptake (V0O2) and
carbon dioxide output (V0CO2) were measured over 5min,
using an automated ergometry set-up (Oxycon Alpha,
Jaeger). Mean values of the last four minutes were taken
for analysis.
Maximal inspiratory (PImax) and expiratory pressures
(PEmax) were measured using a standard flanged mouthpiece
connected to a pressure transducer (M-163, Sibelmed,
Barcelona, Spain). PImax was measured from functional
residual capacity (FRC) and PEmax from total lung capacity
(TLC), using a nose clip.21 At least five repeated determina-
tions were done until three technically satisfactory and
reproducible measurements were obtained (variations in
PImaxo10%). The highest recorded pressures maintained for
1 s were used for analysis.22
Breathing control was evaluated as previously de-
scribed.18 After 20min of rest, patients were asked to
breathe normally through a low-resistance breathing valve
(0.1 kPa/L/s, dead space 75mL). Inspiratory flow was
measured with a pneumotachograph (model 276, Jaeger)
connected to a flow transducer (model DWD, Jaeger) and
volume was obtained by flow signal integration over time.
Mouth pressure was recorded with a differential pressure
transducer (Model DWD, Jaeger). Arterial oxygenation
saturation (SaO2) and CO2 expired were continuously
sampled by a finger-pulse oximeter and a rapidly responding
infrared CO2 analyser (model Oscar II, Datex, Helsinki,
Finland).
The gas analyser was calibrated with gasses previously
analysed by the Scholander technique.23 Pressure, volume,
SaO2 and PETCO2 signals were passed via an analogue-digital
converter (Screenmate Box, Jaeger) to a personal computer
running LabView software (National Instruments, Austin,
Texas, USA) and sampling at 200Hz. Once the subjects felt
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recorded for a few minutes to ensure a steady state. From
the breathing pattern record, we obtained tidal volume
(VT), inspiratory time (tI) and total cycle duration (tTOT).
Expiratory time (tE), duty cycle (tI/tTOT), mean inspiratory
flow (VT/tI) and minute ventilation (VI) were calculated. The
values from 10 cycles were averaged for the analysis of the
results.18 Mouth occlusion pressure at 0.1 s after the
beginning of inspiration (P0.1) was measured by the White-
law method.14 Approximately every 15 s the inspiratory line
was occluded without the subject’s knowledge for less than
0.5 s by means of a pneumatic inflatable balloon (Series
9327; Hans-Rudolph, St. Louis, MO, USA). The mean of at
least five measurements was determined.
P0.1 response to isocapnic progressive hypoxia was
determined using the rebreathing method.24 In the seated
position with nose clips applied, subjects breathed room air
through a mouthpiece via a three-way valve. After a stable
end-tidal CO2 concentration was achieved, subjects re-
breathed through a 7-l bag containing the initial gas
mixture: 21% O2 and 7% CO2 in nitrogen. CO2 was held
constant (PETCO271mmHg) at the resting end-tidal level
(‘‘mixed-venous’’) using a variable CO2 absorber bypass
containing soda lime CO2 absorbent and a variable fan.
Approximately every 15 s without the subject’s knowledge,
mouth occlusion pressure was recorded as indicated
previously. P0.1 was measured from each tracing and was
plotted against SaO2 on linear coordinates and the slope was
calculated by least-squares linear regression. The hypoxic
response trial was terminated when the subjects reached
80% SaO2.
18
Sixty minutes after hypoxic stimulation, P0.1 response to
hyperoxic progressive hypercapnia was measured.25 In the
seated position with nose clips in place, subjects again
breathed room air through a three-way valve until PETCO2
sampled at the mouthpiece was stable (71mmHg). The
valve was then turned so that subjects rebreathed a gas
mixture (7% CO2 and 93% O2) from a 7-l bag. P0.1 and PETCO2
were measured and recorded as previously described. P0.1
was plotted against PETCO2 and the slope was also calculated
by least-squares linear regression using the equation P0.1 ¼ S
(PETCO2B), where S is the slope and B is the extrapolated
intercept on the abscissa (PETCO2 axis). The trial of
hypercapnic response was terminated when the subjects
reached 64mmHg PETCO2 or PETCO2 increased 10mmHg
or more.18Table 1 Anthropometric characteristics of the study groups.a
20–40 yrs 65–69 yrs
(n ¼ 47) (n ¼ 16)
Males, n (%) 28 (59) 9 (56)
Height (cm) 16275 16179
Weight (kg) 66711 72712
BMI (kg/m2) 25.273.9 27.473.1
BSA (m2) 1.7070.14 1.7670.19
Abbreviations: BMI, body mass index; BSA, body surface area. No sig
aResults are mean7SD.Statistical analysis
Values are expressed as mean7SD. All statistical tests were
two-sided. The chi-square test was used to evaluate
frequencies. The comparisons between the groups were
performed by means of analysis of variance with post-hoc
multiple comparisons by the Bonferroni test. Relationships
between variables were determined by Pearson correlation
analysis.26 These analyses were performed using the
Statistical Package for the Social Sciences 10.0 (SPSS Inc.,
Chicago, IL). P-values of o0.05 were considered to be
significant.Results
The final number of subjects who completed all the
determinations and their anthropometric characteristics
are shown in Table 1. Seven 65–85 year-old subjects were
excluded from the analysis due to their inability to perform
acceptable and reproducible lung function tests. No
differences in anthropometric characteristics were noted
between the excluded and the analysed elderly subjects.
Regarding gender distribution and body size, there were no
significant differences between the healthy young controls
and the four groups of elderly subjects. Baseline lung
function parameters are shown in Table 2.
No consistent changes in breathing pattern were detected
except for minute ventilation, which was higher in the 65–74
year-old subjects and in the groups over the age of 75 than
in healthy young controls (Table 3). Central inspiratory
drive, assessed by mouth occlusion pressure (P0.1) as well as
by P0.1 adjusted to inspiratory muscle strength (P0.1/PImax),
showed a significant increase compared to young healthy
controls in age groups 65–69 and 70–74, but this difference
was not observed in the older groups (Fig. 1).
Peripheral chemosensitivity, as assessed by the P0.1
response to progressive isocapnic hypoxia, presented
characteristic declining patterns in the elderly subject
groups (Table 3). Figure 2 clearly shows that hypoxic
sensitivity gradually decreased as age increased until the
ages of 70–74, remaining unchanged from 75 onward. No
significant differences in CO2 sensitivity were found
between the study groups. However, CO2 threshold was
lower in the elderly groups than in healthy young controls
(Fig. 3).70–74 yrs 75–79 yrs 80–84 yrs
(n ¼ 18) (n ¼ 16) (n ¼ 15)
10 (56) 9 (56) 8 (53)
15878 16179 15777
6876 69711 6475
27.072.1 26.772.3 26.271.4
1.6970.12 1.7370.18 1.6570.10
nificant differences among groups have been detected (ANOVA).
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Table 2 Lung volumes, diffusion capacity of carbon monoxide, maximal static respiratory pressures, blood gases and
baseline metabolic rate in the study groupsa
20–40 yrs 65–69 yrs 70–74 yrs 75–79 yrs 80–84 yrs
(n ¼ 47) (n ¼ 16) (n ¼ 18) (n ¼ 16) (n ¼ 15)
FVC (L) 3.5070.45 2.9970.78y 2.8470.61z 2.9870.64y 2.8270.71z
FEV1 (L) 3.0270.34 2.2670.65
y 2.2570.54y 2.1470.61y 1.8070.53y
FEV1/FVC (%) 86.774.7 75.576.1
y 79.275.7y 71.376.2y# 63.477.7yz#|
FRC (L) 2.7370.49 2.8870.56 2.7770.85 2.7770.61 2.6270.43
TLC (L) 5.0670.74 5.1671.25 5.0571.30 5.0771.10 4.3770.73
RV (L) 1.4270.37 2.1670.65y 2.0370.75y 2.0570.43y 2.0470.33z
RV/TLC (%) 28.075.5 41.877.0y 39.377.7y 40.674.5y 47.075.7y#|
DLCOc (mL/min/mmHg) 28.075.0 25.477.2 24.376.8 22.674.7z 19.471.9y!
PImax (kPa) 9.371.3 8.270.8z 7.170.7y 7.070.6y! 6.970.6y!
PEmax (kPa) 10.971.8 10.172.0 9.671.7 8.470.9y 8.270.6y!
pH 7.44070.025 7.44170.016 7.44170.030 7.43670.021 7.44270.045
PaO2 (mmHg) 89.275.2 78.572.2
y 76.575.8y 76.275.7y 76.774.1y
PaCO2 (mmHg) 37.873.6 37.774.1 36.372.8 39.072.6 38.672.4
PA-aO2 (mmHg) 1.873.2 15.979.9
y 20.878.4y 16.174.7y 14.974.9y
V0O2 (mL/min) 190712 215758 218746 188749 177733
!#
V0CO2 (mL/min) 147710 188768
y 192748z 156738 144728!#
RQ 0.7870.01 0.8670.13y 0.8870.12z 0.8470.05 0.8270.10
VD/VT 0.3470.04 0.3770.03 0.4170.10
z 0.4570.02y! 0.4470.04y!
Abbreviations: FVC, forced vital capacity; FEV1, forced expiratory volume at 1 s; FRC, functional residual capacity; TLC, total lung
capacity; RV, residual volume; DLCOc, haemoglobin-corrected diffusion capacity of carbon monoxide; PImax, maximal static
inspiratory pressure; PEmax, maximal static expiratory pressure, PaO2, arterial oxygen partial pressure; PaCO2, arterial carbon dioxide
partial pressure; PA-aO2, alveolar-arterial gradient of oxygen; V0O2, oxygen uptake; V0CO2, carbon dioxide production; RQ, respiratory
quotient; VD/VT, physiologic dead space/tidal volume. All lung volumes and capacities are BTPS and V0O2 and V0CO2 are STPD.
Comparisons with 20–40 yrs (ANOVA): yPo0.05, zPo0.01, and yPo0.001. Comparisons with 65–69 yrs: !Po0.05, and zPo0.01.
Comparisons with 70–74 yrs: #Po0.01. Comparisons with 75–79 yrs: | Po0.01.
aResults are mean7SD.
Table 3 Breathing pattern, central inspiratory drive and chemosensitivity in the study groups.a
20–40 yrs 65–69 yrs 70–74 yrs 75–79 yrs 80–84 yrs
(n ¼ 47) (n ¼ 16) (n ¼ 18) (n ¼ 16) (n ¼ 15)
VT (L) 0.59670.087 0.62070.119 0.57970.146 0.66170.164 0.69070.078
VT/BSA (L/m
2) 0.34970.046 0.35770.078 0.34370.089 0.38670.097 0.41970.040z#
tI (s) 1.4970.34 1.7370.44 1.6670.48 1.8770.52
y 1.6470.34
tTOT (s) 3.2570.55 3.4270.52 3.0370.78 3.3970.65 3.4070.34
VT/tI (L/s) 0.42070.108 0.37770.104 0.37870.145 0.36070.057 0.43770.111
tI/tTOT 0.45770.063 0.50770.103 0.55370.108
y 0.55070.075z 0.48270.068
tE (s) 1.7670.36 1.6970.46 1.3770.53
z 1.5170.31 1.7570.24
f (min1) 19.073.7 18.072.9 21.275.9 18.272.7 17.872.0
VI (L/min) 11.3072.43 10.9471.67 11.9172.97 11.7872.00 12.4072.64
VI/BSA (L/min/m
2) 6.5571.31 6.3071.22 7.0671.84 6.8871.43 7.5171.42
P0.1 (kPa) 0.1570.04 0.1870.02
y 0.2070.05y 0.1570.02# 0.1570.02#
P0.1/PImax 0.01670.004 0.02370.004
y 0.02970.009y 0.02170.003z# 0.02270.002y#
P0.1/SaO2 (kPa/%) 0.031170.0076 0.025470.0041
# 0.018170.0020yz 0.012570.0033y’’# 0.012270.0025y’’#
S (kPa/mmHg) 0.050870.0297 0.050470.0208 0.037670.0249 0.042870.0095 0.038870.0082
B (mmHg) 38.571.0 35.872.6z 33.773.4y 34.973.3y 36.272.4y#
Abbreviations: VT, tidal volume; tI, inspiratory time; tTOT, total respiratory cycle time; VT/tI, mean inspiratory flow; tI/tTOT, duty cycle;
tE, expiratory time; f, breathing frequency; VI, minute ventilation; BSA, body surface area; P0.1, mouth occlusion pressure at 0.1 s after
the beginning of inspiration, PImax, maximal static inspiratory pressure, P0.1/SaO2, central inspiratory drive response to progressive
isocapnic hypoxic stimulation; S, slope of the central inspiratory drive response to progressive hyperoxic hypercapnic stimulation; B,
extrapolated intercept on the abscissa of the central inspiratory drive response to progressive hyperoxic hypercapnic stimulation.
Comparisons with 20–40 yrs (ANOVA): yPo0.05, zPo0.01, and yPo0.001. Comparisons with 65–69 yrs: zPo0.01, and ’’Po0.001.
Comparisons with 70–74 yrs: #Po0.01
aValues are mean7SD.
Chemosensitivity in elderly 2195
ARTICLE IN PRESS
Figure 1 Individual distribution of the central inspiratory
drive, as assessed by mouth occlusion pressure (P0.1), and in the
study subjects by age groups. The horizontal lines represent the
mean.
Figure 2 Individual distribution of the inspiratory central drive
response to progressive isocapnic hypoxic stimulation (P0.1/
SaO2) in the study subjects by age groups. The horizontal lines
represent the mean.
Figure 3 Individual distribution of the CO2 sensitivity thresh-
old (extrapolated intercept on the abscissa of the inspiratory
central drive response to progressive hyperoxic hypercapnic
stimulation or B) in the study subjects by age groups. The
horizontal lines represent the mean.
F. Garcı´a-Rı´o et al.2196The variables potentially related to breathing control
were analysed in the four elderly subject groups together.
When variables were adjusted to body size, only significant
differences attributed to gender were detected in the
sensitivity to CO2. The elderly women had lower P0.1
responses to hypercapnia than the men (0.035270.0131
vs. 0.047370.0019 kPa/mmHg, P ¼ 0.007). No correlations
between the anthropometric characteristics of the elderly
subjects and their breathing pattern and central inspiratory
drive were found. As in young healthy controls, lung volume,
inspiratory muscle strength and basal metabolic rate were
the principal determinants of hypoxic sensitivity. Specifi-
cally, P0.1 response to hypoxia was directly related to weight
(r ¼ 0.313, P ¼ 0.011), total lung capacity (0.270,
P ¼ 0.031), PImax (r ¼ 0.557, Po0.001) and oxygen uptake
(r ¼ 0.417, P ¼ 0.001). Finally, the P0.1 response to hyper-
capnia was related to height (r ¼ 0.470, P ¼ 0.011) and
weight (r ¼ 0.324, P ¼ 0.002).Discussion
This study demonstrates that healthy elderly subjects
experience a progressive reduction in sensitivity to hypoxiauntil the age of 75, which stabilises thereafter, as well as a
decrease in CO2 threshold.
In this study, the ventilatory responses were assessed by
the mouth occlusion pressure (P0.1). We have chosen to use
the P0.1 instead of the minute ventilation to avoid problems
posed by a poor neuron-mechanical coupling. In fact, the
elderly subjects may develop upper and lower airway
resistance,2 which might damp the translation of ventilatory
drive from respiratory centers to alveolar ventilation.
Different factors may contribute in modifying the
respiratory response to hypoxia. No relevant differences
were detected in either pH or PaCO2 among our study
groups. Previous studies have excluded age-related altera-
tions in muscle strength and respiratory compliance as
mechanisms responsible for the reduced hypoxic response in
the elderly.27,28 Another important factor is the relationship
between basal metabolism and sensitivity to hypoxia, given
that it has been demonstrated that the increase in oxygen
consumption emphasises the response to hypoxia.29 How-
ever, this parameter also does not vary in our series between
the groups of aged subjects and healthy young controls.
Still, without being able to categorically rule out that the
decrease in the response to hypoxia observed in the older
groups is due to either a reduction in the neural impulse
towards the inspiratory muscles, lower mechanical effi-
ciency, or not being physically fit, it seems to reflect above
all a loss of peripheral chemosensitivity.
In the loss of sensitivity of the carotid body to hypoxia,
the changes in cerebral blood flow during hypoxic stimula-
tion do not seem to play a relevant role.30 On the contrary, it
is possible that the loss of sensitivity of the carotid body is
due to alterations at the glomus cell level.31 Using
ultrastructural studies in laboratory animals, it has been
reported that ageing induces a series of degenerative
changes in the glomus cells as well as thickening of the
connective tissue that surrounds the lobes of the chemo-
receptor cells.32
The intrinsic mechanism causing a blunting of the
peripheral chemosensitivity to develop during the ageing
process is not well defined, one of the reasons being the
limited knowledge about oxygen sensitivity mechanisms. In
normal adults, it has been reported that the excitability of
ARTICLE IN PRESS
Chemosensitivity in elderly 2197the glomus cells of the carotid body when faced with a
decrease in PO2 is determined by the modulation of the
activity of diverse ion channels in the membranes. It has
been proposed that the closure of K+ channels by low PO2
leads to membrane depolarisation and/or increase of action
potential firing frequency, extracellular Ca2+-influx through
voltage-gated channels, and transmitter release to the
extracellular milieu.33 However, sensitivity to oxygen is not
intrinsic of the ionic channels; it requires the participation
of activation mechanisms. Among these are the interaction
between O2-sensing signalling molecules, the pore-forming
channel subunits and the redox model of acute O2 sensing,
based on the conversion of O2 into reactive oxygen species
(ROS), which would then alter the cellular redox status and
the function of the ion channels.33,34 Mitochondria have also
been considered by some authors to be the site for acute O2
sensing because, similar to hypoxia, inhibitors of the
electron transport chain and metabolic poisons stimulate
the carotid body. The lack of O2 would reduce the activity of
cytochrome c oxidase in complex IV, thus resulting in
mitochondrial depolarisation and Ca2+ release.34
Ageing could alter the function of some ionic channels or
alter the redox balance. In other organs, it has been shown
that old age induces functional changes in the voltage-gated
K+ channels of some neurons, which translates into lower
sensitisation.35 On the other hand, the free radical theory of
ageing states that multicellular organisms undergo qualita-
tive changes with ageing that are associated with an
intensified generation of ROS. In fact, it has been demon-
strated that the elderly have lower blood catalase activity,
which would favour a supposed pro-oxidant state.36 It has
been demonstrated that ROS generation is intensified in
elderly individuals,37 which could reduce tyrosine hydro-
xylase activity38 and, consequently, reduce the synthesis
and release of neurotransmitters from the glomus cells of
the carotid body. In fact, there are several studies in humans
suggesting that ROS have an inhibiting effect on the
acute hypoxic ventilatory response and showing a relation-
ship between the hypoxic ventilatory response and anti-
oxidants.39–41
To our knowledge, the evolution of the sensitivity to
hypoxia during the ageing process has not been described in
previous studies. The stabilisation of the blunting after the
age of 75 is difficult to justify in light of current knowledge.
It could simply be the result of a process of natural selection
by which subjects with lower peripheral chemosensitivity
die earlier. However, it could also reflect a process of
adaptation to lower PO2 tension. Intermittent hypoxia sets
off an abrupt increase in the production of ROS, particularly
O2
, giving rise to periodical augmentation of cytosol [Ca2+],
which increases tyrosine hydroxylase expression and initi-
ates the cellular hypoxic cascade.36 We should also not rule
out adaptive long-term changes induced by chronic hypoxia.
In fact, it has been demonstrated that maintained reduc-
tions in O2 tension induce a blunted response to low PO2.
42 It
has been reported that glomus cells from chronically
hypoxic carotid bodies are more excitable due to the
overexpression of Na+ and Ca2+ channels, but they also have
reduced voltage-dependent K+ current amplitude.42
When analysed by age periods, no changes were detected
in the response to hypercapnia in old age. This circum-
stance, which could be justified only by the limited samplesize reached, contrasts with the inversion of the behaviour
of the CO2 threshold, which descends until the age of 75, to
increase once again after said age (Fig. 3). The decrease in
the CO2 threshold merits consideration. Although our data
do not allow us to exclude other possibilities, it could simply
be a compensatory response to control the increase in PCO2
in the central nervous system. Previous studies have shown a
decrease in cerebral blood flow with increasing age.43 This
decrease would result in a higher prevailing PCO2 at the
central chemoreceptors for a given level of PaCO2 in the
elderly.
The reduction of the CO2 threshold can have important
clinical consequences. Even though it has been demon-
strated that the night-time decrease in sensitivity to CO2
does not play much of a role in the development of central
apnoea,44 the decrease of the CO2 threshold could make a
greater contribution. With a lower CO2 threshold, a
relatively small sleep-related increase in PETCO2 could cause
the age related increased frequency of arousal,45 which
gives rise to greater sleep fragmentation and a less restful
sleep. In fact, it has been demonstrated that increases in
PETCO2 could be capable of inducing arousals in humans in
the absence of changes in the activity of the respiratory
mechanoreceptors.46 Arousals may be associated with
hyperventilation and secondary hypocapnia, which in turn
may lead to central apnea as sleep resumes. In contrast with
the negative effects of the reduction of the CO2 threshold,
the blunted hypoxic ventilatory responses found in elderly
subjects could have beneficial implications. It is known that
a blunted chemosensitivity can stabilise the breathing
during sleep and, therefore, it would diminish the risk of
periodic breathing during the ageing process.
In conclusion, this study shows that during the ageing
process there is a progressive blunting in the sensitivity to
hypoxia and a reduction in the CO2 threshold, both
alterations becoming stable after the age of 75. The clinical
implications of the changes described in the breathing
regulation system during old age now need to be explored,
although one of the most attractive aspects is its likely
relationship with the development of respiratory disorders
during sleep.
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